Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony-stimulating factor

Arch Dermatol. 1999 Oct;135(10):1276-7. doi: 10.1001/archderm.135.10.1276.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage*
  • Humans
  • Injections, Intralesional
  • Melanoma / drug therapy*
  • Recombinant Proteins / administration & dosage
  • Remission Induction
  • Scalp*
  • Skin Neoplasms / drug therapy*

Substances

  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor